Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03364231
Title Study to Assess the Efficacy and Safety of Umbralisib in Patients With Non-Follicular Indolent Non-Hodgkin's Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors TG Therapeutics, Inc.
Indications

marginal zone B-cell lymphoma

Waldenstroem's macroglobulinemia

Therapies

Umbralisib

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.